Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All-Cause Mortality.
Stage: observational
· pubmed
· 01-oct-2026
If you are comparing a consumer proteomic organ-age panel against a GrimAge2-style methylation report or standard clinical measures like brain MRI, lung function, and cognitive testing, in this cohort the organ-age panels carried less 16-year mortality information than those alternatives.
In the Lothian Birth Cohort 1936, proteomic liver, immune and heart ageing clocks predicted 16-year all-cause mortality, but GrimAge2, smaller brain volumes, reduced respiratory function and poorer cognition showed stronger associations, while GDF15, WFDC2 and TIMP1 led a 368-protein mortality signature.
Link: /findings/1453